Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Bayer Inc
Scientific Title
A MULTINATIONAL, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III EFFICACY AND SAFETY STUDY OF ODM-201 IN MEN WITH HIGH-RISK NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER